Causal links between gut microbiota, plasma metabolites, and insomnia: Insights from Mendelian randomization

XuWen Zheng1, Jin Xu1, JinNan Yin1

  • 1Department of Emergency, Wujin Hospital Affiliated with Jiangsu University and Wujin Clinical College of Xuzhou Medical University, Changzhou, Jiangsu, China.

PubMed
Abstract

Insights

Gut bacteria influence insomnia risk through plasma metabolites. Specific gut microbiomes and 3-ethylcatechol sulphate levels mediate this connection, offering potential therapeutic targets for sleep disorders.

Area of Science:

  • Microbiome research
  • Metabolomics
  • Sleep science

Background:

  • The gut microbiome plays a role in the gut-brain axis.
  • Understanding the link between gut microbiota and insomnia is crucial for public health.
  • Plasma metabolites may mediate the effects of gut bacteria on sleep.

Purpose of the Study:

  • To investigate the mediating role of plasma metabolites in the relationship between gut microbiomes and insomnia.
  • To identify specific gut bacteria and plasma metabolites associated with insomnia.
  • To explore potential therapeutic targets for insomnia based on gut-brain axis interactions.

Main Methods:

  • Mendelian randomization (MR) analysis was used to explore causal relationships.
  • Genome-wide association study (GWAS) data for gut microbiota and plasma metabolites were utilized.
  • Mediation effects were calculated using the product of coefficients approach.

Main Results:

  • Ten gut microbiomes and 35 plasma metabolites were found to be potentially associated with insomnia.
  • Increased abundance of certain gut microbiomes, like CAG-145 sp000435615, correlated with higher insomnia risk.
  • Plasma metabolite 3-ethylcatechol sulphate significantly mediated the effect of gut microbiomes on insomnia, explaining up to 31.49% of the total effect.

Conclusions:

  • Gut microbiota composition influences insomnia risk.
  • Plasma metabolites, such as 3-ethylcatechol sulphate, act as mediators in the gut-brain axis concerning insomnia.
  • These findings suggest novel therapeutic strategies for managing insomnia by targeting the gut microbiome and its metabolites.

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
744
Insomnia01:27

Insomnia

Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
549
Circadian Rhythms and Gene Regulation02:19

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.6K
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
706
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
88.7K
Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
1.1K